Proteomics Takes on a Central Role in Life Science Industry; Surging at 18% CAGR

April 07, 2015

Wellesley, Mass., April 07, 2015 –BCC Research ( reveals in its new report on proteomics, the global market is growing at a compound annual growth rate (CAGR) of 18% to reach a forecast value of $11.6 billion by 2019.

The proteomics industry contains a diverse set of platforms, market segments, and competitors. The industry is attractive because it complements the large genomics industry, providing additional data for understanding biological systems. Innovation within the industry is a source of competitive advantage, and is able to drive adoption among users in the life sciences.

The two key proteomic technologies—mass spectrometry and biochips—are benefiting from an explosion of new proteomic content from the large-scale genomic and proteomic initiatives. This proteomic content is driving the discovery of new biomarkers that are important in disease processes.

Novel technologies are also driving proteomic applications. For example, increasing miniaturization and integration is occurring in biochip devices, and improvements in mass spectrometry workflow and instruments. These innovations are driving proteomics applications in important markets like drug discovery and development and diagnostics.

“Some key factors driving this industry include: a growing pipeline of diagnostics using proteomics mass spectrometry and biochips platforms; corporate deal-making between proteomics biotechnology companies and large pharma/instrument suppliers; an explosion in genomics-driven discovery; and the rise of novel multi-omics and integrated proteomics platforms, and single-cell proteomics.,” says BCC Research analyst John Bergin.

Proteomics thus takes on a central role in understanding biological systems and human diseases. The proteomics industry and markets are an important component of the biotechnology and life sciences industries, and are thus of interest to a wide audience.

Proteomics: Technologies and Global Markets seeks to provide a qualitative and quantitative description of the agricultural biotechnology industry. It determines the status of proteomic technologies and products and assesses their global growth potential over the five-year period from 2014 to 2019. The study scope covers mass spectrometry (MS) instruments, consumables, workflow products, planar arrays, bead arrays and lab-on-a-chip (LOAC). It also covers the research, drug discovery and development, diagnostics and applied end-user market segments.


To Contact us, click here  help

Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at

Proteomics: Technologies and Global Markets( BIO034D )
Publish Date: Feb 2015    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.